Missed opportunity: Aldosterone antagonists in heart failure

December 2009
Internal Medicine Alert;12/29/2009, Vol. 31 Issue 24, p192
The article presents a study conducted by the New York Heart Association (NYHA) on the utilization of aldosterone antagonists to support the standard-of-care treatment of the Class III-IV systolic heart failure through the Seminal Rales Trial.


Related Articles

  • Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). Zannad, Faiez; McMurray, John J.V.; Drexler, Helmut; Krum, Henry; van Veldhuisen, Dirk J.; Swedberg, Karl; Shi, Harry; Vincent, John; Pitt, Bertram // European Journal of Heart Failure;Jun2010, Vol. 12 Issue 6, p617 

    Aims: In chronic heart failure (HF), aldosterone antagonists have been shown to improve survival in patients with low ejection fraction and moderate-to-severe symptoms [New York Heart Association (NYHA) classes III and IV]. Efficacy of these agents was also shown when they were administered to...

  • New data from studies bolsters case for using aldosterone antagonists in heart failure.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p836 

    The article reports that medical expert Bertram Pitt will review the data from three prominent studies on aldosterone antagonists for heart failure therapy in a presentation at the American Physiological Society conference.

  • 555 Indirect comparison of the effects of adding an aldosterone antagonist or an angiotensin receptor blocker in severe heart failure: new data from the CHARM-Added trial. Weir, R.A.P.; McMurray, J.J.V.; Granger, C.B.; Olofsson, B.; Ostergren, J.; Yusuf, S.; Swedberg, K.; Pfeffer, M.A.; CHARM Investigators // European Journal of Heart Failure. Supplements;Jun2006, Vol. 5 Issue 1, p124 

    An abstract of the study "Indirect Comparison of the Effects of Adding an Aldosterone Antagonist or an Angiotensin Receptor Blocker in Severe Heart Failure: New Data From the CHARM-Added Trial," by R. A. P. Weir and colleagues is presented.

  • Analysis of the advantages of peritoneal dialysis in the treatment of chronic refractory heart failure. Sánchez, J. E.; Rodríguez, C.; González, I.; Fernández-Viña, A.; Núñez, M.; Peláez, B. // Nefrologia;Oct2010, Vol. 30 Issue 5, p487 

    The author reflects on the advantages of peritoneal dialysis (PD) in treating chronic refractory heart (RH) failure in Barcelona, Spain. He states that patients have experienced a functional improvement through PD as evaluated in the New York Heart Association scale (NYHA). He notes that the use...

  • Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study. Conceição-Souza, Germano Emílio; Pêgo-Fernandes, Paulo Manuel; Cruz, Fatima das Dores; Guimarães, Guilherme Veiga; Bacal, Fernando; Vieira, Marcelo Luiz Campos; Grupi, Cesar José; Giorgi, Maria Clementina Pinto; Consolim-Colombo, Fernanda Marciano; Negrão, Carlos Eduardo; Rondon, Maria Urbana P.; Moreira, Luiz Felipe Pinho; Bocchi, Edimar Alcides // European Journal of Heart Failure;Dec2012, Vol. 14 Issue 12, p1366 

    Aims To evaluate the feasibility, safety, and potential beneficial effects of left cardiac sympathetic denervation (LCSD) in systolic heart failure (HF) patients. Methods and results In this prospective, randomized pilot study, inclusion criteria were New York Heart Association (NYHA) functional...

  • The impact of pathways: a significant decrease in mortality. Panella, Massimiliano // International Journal of Care Pathways;Nov2009, Vol. 13 Issue 2, p57 

    This study was undertaken to determine how care pathways (CPs) in the hospital treatment of heart failure (HF) affected in- hospital mortality, and outcomes at discharge. A two-arm, cluster randomized trial was conducted. Fourteen community hospitals were randomized either to arm 1 (CPs) or to...

  • Transesophageal left ventricular electrogram-recording and temporary pacing to improve patient selection for cardiac resynchronization. Heinke, Matthias; Ismer, Bruno; Kühnert, Helmut; Figulla, Hans // Medical & Biological Engineering & Computing;Aug2011, Vol. 49 Issue 8, p851 

    Cardiac resynchronization therapy (CRT) with biventricular pacing (BV) is an established therapy for heart failure (HF) patients with inter- and intraventricular conduction delay. The aim of this pilot study was to test the feasibility of both transesophageal measurement of left ventricular (LV)...

  • Long-term effects of pentoxifylline in heart failure therapy. Karagöz, Ahmet; Uçar, Özgül; Yüksel, Ayşe; Aydoğdu, Sinan // Journal of Experimental & Clinical Medicine;Mar2014, Vol. 31 Issue 1, p19 

    The aim of the present study is to investigate the effects of pentoxifylline on left ventricular ejection fractions (EF) and volumes, New York Heart Association (NYHA) functional class, left ventricular diastolic parameters and hospitalization for heart failure in patients with ischemic or...

  • Independent Nurse: Clinical - Classifying heart failure. Bell, Suzanne // GP: General Practitioner;6/11/2010, p20 

    The article offers information on the New York Heart Association (NYHA) classification tool of heart failure. It mentions that the tool is based on severity of a patient's symptoms. It informs that the tool can be used with general medicine for the acute and primary care of chronic heart failure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics